Alcentra supports Ardian's acquisition of Groupe Bio 7
Alcentra has provided a unitranche debt package to support Ardian’s purchase of French laboratory operator Groupe Bio 7.
Alcentra provided the debt package alongside Bank of Ireland and Hayfin Capital Management.
Ardian acquired Groupe Bio 7 in early June in a secondary buyout from Chequers Capital.
Founded in Essonne in 1991, Bio 7 operates more than 50 clinical analysis laboratories. In 2014 the company expects to generate turnover of more than €55m.
The deal marks Alcentra's sixteenth investment since it launched its direct lending strategy in 2013. Other deals include Mountain Warehouse, Cambridge Education and Caffe Nero.
More on France
Naxicap to exit ECF in SBO to PAI
Hospitality and care equipment producer marks fifth deal from PAI’s eighth flagship fund
Cerea Partners raises EUR 700m-plus for multi-asset food and beverage funds
France-headquartered GP is on the road for vehicles across its private equity, mezzanine and senior debt strategies
Montagu exits Maincare to state-owned Docaposte in off-market deal
Hospital software group considered "missing piece" in buyer's healthcare digitalisation strategy
Mircap nears first close for debut co-investment fund
GP led by Michele Mezzarobba and François Pinel de Golleville will aim to raise EUR 100-120m
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds